MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
available for sale
$539,929K
(-38.36%↓ Y/Y)
Cash and cash
equivalents
$165,810K
(521.57%↑ Y/Y)
Prepaid clinical trial
and preclinical...
$8,053K
(131.67%↑ Y/Y)
Prepaid expenses and
other current assets
$1,806K
(60.11%↑ Y/Y)
Total current assets
$715,598K
(-21.12%↓ Y/Y)
Right-of-use assets
$85K
(-91.53%↓ Y/Y)
Deposits
$46K
(0.00%↑ Y/Y)
Total assets
$715,729K
(-21.20%↓ Y/Y)
Total liabilities and
stockholders equity
$715,729K
(-21.20%↓ Y/Y)
Total stockholders
equity
$639,062K
(-27.40%↓ Y/Y)
Total liabilities
$76,667K
(173.39%↑ Y/Y)
Accumulated deficit
-$847,546K
(-73.71%↓ Y/Y)
Additional paid-in capital
$1,486,229K
(8.57%↑ Y/Y)
Total current
liabilities
$76,667K
(179.67%↑ Y/Y)
Accumulated other
comprehensive loss
$378K
(147.97%↑ Y/Y)
Common stock, 0.00001
par value...
$1K
(0.00%↑ Y/Y)
Accounts payable
$53,251K
(442.66%↑ Y/Y)
Other accrued
liabilities
$23,279K
(36.05%↑ Y/Y)
Lease liability,
current
$137K
(-71.98%↓ Y/Y)
Back
Back
Balance Sheet
source: myfinsight.com
viking_9_15_logo-svg
Viking Therapeutics, Inc. (VKTX)
viking_9_15_logo-svg
Viking Therapeutics, Inc. (VKTX)